
Venus Remedies Limited has informed the Exchange regarding a press release dated May 16, 2023, titled "VENUS REMEDIES LIMITED (VRL) RECOGNIZED FOR ITS IN-HOUSE R&D EXCELLENCE BY THE DEPARTMENT OF SCIENTIFIC AND INDUSTRIAL RESEARCH (DSIR)".
Filed with NSE ·

Venus Remedies Limited has informed the Exchange regarding a press release dated May 16, 2023, titled "VENUS REMEDIES LIMITED (VRL) RECOGNIZED FOR ITS IN-HOUSE R&D EXCELLENCE BY THE DEPARTMENT OF SCIENTIFIC AND INDUSTRIAL RESEARCH (DSIR)".
6ix hasn’t read this filing yet.
Follow Venus Remedies into a list and get an email when it puts out news.
Follow Venus Remedies